Back to Search

NAGE

Niagen Bioscience, Inc. Common Stock
Data: 2026-08-24
$3.22
Price
0.31%
Change
$10.52
52W High
$2.87
52W Low
Full AI Analysis Buy/Sell Forecast Trendline Why Moving Charts Options

Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.

Quick Stats
Aug 24, 2026

41.5

AI Score

HOLD

0.32

Volume Ratio

TBA

Next Earnings

17

+ve Days (30d)

13

-ve Days (30d)

NAGE Stock Summary

Last updated Aug 24, 2026

NAGE is currently trading at $3.22, positioned below its 200-day moving average of $4.83, suggesting bearish momentum. The stock has a 52-week range of $2.87 to $10.52.

Technical Analysis: The 50-day moving average stands at $3.3, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 50.591, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.238, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates NAGE at 41.5/100 with a HOLD recommendation.

NAGE (Niagen Bioscience, Inc. Common Stock) Indicators

Last updated Aug 24, 2026

Indicator Value
RSI(14) 50.591
CMF (20) 0.238
ROC (10) 5.41
ADX (14) 15.758
Indicator Value
MACD (12,26,9) -0.052
AROONOSC (14) -7.143
WILLAMS %R (14) -15.854
MFI (14) 42.873
NAGE Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

NAGE Price vs Max Options Open Interest
NAGE Max Change In Options Open Interest

NAGE Options - Sort by Max open Interest (near term)

24th August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

NAGE Daily Out of Money Options - Sort by Max open Interest (near term)

24th August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

NAGE Daily In the Money Options - Sort by Max open Interest (near term)

24th August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

NAGE Most Active Options by Volume(near term)

24th August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI		 Ask PC Delta Vega Volatility % change Track

Niagen Bioscience, Inc. Common Stock is below both the 50 Day and 200 Day SMA which is considered Bearish.

NAGE Moving Averages Analysis

NAGE (Niagen Bioscience, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Aug 24, 2026

Days MA
10 3.11
20 3.17
30 3.23
50 3.3
100 3.76
200 4.83

NAGE Fundamental Analysis

P/E (Forward) 22.6244
P/E (Trailing) 16.5789
Market Cap ($) 250.9 million
Earnings/Share ($) 0.19
Net Profit Margin (%) 0.1239
Dividend/Share ($) --
EPS Estimate Current Year ($) 0.09
EPS Estimate Next Year ($) 0.1
WallStreet Target Price ($) 12.08
Most Recent Quarter